Japan To Accept Foreign Data; USTR Requests Dispute Settlement For Canada
Executive Summary
The Japanese government has agreed to accept foreign clinical data for approval of new drugs when the data meets or is equivalent to Japanese or International Conference on Harmonization Good Clinical Practice standards.
You may also be interested in...
Canadian Price Controls May Become Higher Priority For PhRMA
The impact of international pharmaceutical price controls on the U.S. Medicare debate may be leading PhRMA to step up its international lobbying efforts, particularly in Canada.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011